Inhaled corticosteroid use to prevent severe vaso-occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial.

ABSTRACT:

SUBMITTER: Vance Utset L 

PROVIDER: S-EPMC5842125 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature